EHRA Premium Access

Adequate ICD treatments after the use of the wearable cardioverter-defibrillator - First results from the swiss nationwide WCD registry

Congress Presentation

About the speaker

Doctor Boldizsar Kovacs

University of Michigan Hospital, Ann Arbor (United States of America)
0 follower

14 more presentations in this session

Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.

Speaker: Mr J. Ramos Maqueda (Zaragoza, ES)


Implantable cardioverter defibrillator and resynchronisation therapy in patients with dilated cardiomyopathy:efficiency in prevention of sudden cardiac death


Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter defibrillator.

Speaker: Associate Professor I. Diemberger (Bologna, IT)


Appropriate and inappropriate ICD therapy with evidence-based programming: a real-world comparison with trial data

Speaker: Doctor M. Chapman (Middlesbrough, GB)


Determinants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization capabilities

Speaker: Doctor R. Brenner (St. Gallen, CH)


Access the full session

Poster session 2 - Implantable Cardioverter / Defibrillator

Speakers: Doctor B. Kovacs, Mr J. Ramos Maqueda, Associate Professor I. Diemberger, Doctor M. Chapman, Doctor R. Brenner

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk